Press Room

JDRF Canada Recognizes Volunteers

During National Volunteer Week 2012, JDRF celebrates and recognizes our extraordinary volunteers. This year’s theme is Passion. Action. Impact. These words truly capture the tremendous commitment and dedication our volunteers demonstrate through their unwavering support.

JDRF Applauds the Government of Manitoba

Insulin pump technology provides precise insulin delivery continuously day and night, helping individuals maintain glucose levels between meals, during exercise and overnight. Studies have shown that people living with type 1 diabetes who use insulin pump therapy experience fewer complications and live ...

Increased Support for Type 1 Diabetes

Edmonton (April 18, 2012) – With the Alberta 2012 Provincial Election underway, various Political Parties in the upcoming election are creating awareness around type 1 diabetes (T1D), its complications and the management of the disease.

Clinical Trial Aims to Optimize the Transition

London, Ontario (April 20, 2012) – JDRF Canadian Clinical Trial Network (JDRF CCTN) is pleased to announce the launch of the Structured Transition from Pediatric Care to Adult Care in Type 1 Diabetes Trial (Transition Trial). Led by Dr. Cheril Clarson at the Children’s ...

JDRF Announces Research Collaboration with Dexcom

NEW YORK, April 24, 2012 - JDRF, the leading global organization focused on type 1 diabetes (T1D) research, announced today that it has partnered with Dexcom, Inc. (NASDAQ:DXCM), a San Diego, CA-based medical device company focused on developing and marketing continuous glucose monitoring (CGM) ...

Increased Support for Insulin Pump Coverage for Albertans

Toronto (April 27, 2012) – With the 2012 provincial election results in, Albertans gave Premier Alison Redford and the Progressive Conservative Party another mandate; to continue to serve the people of Alberta. During the election campaign, the Progressive Conservative Party proclaimed their support ...

Study Aims to Increase Adoption of Advanced Diabetes Technology

Hamilton, ON (May 22, 2012) – JDRF Canadian Clinical Trial Network (JDRF CCTN) is pleased to announce the launch of the Hamilton site of the first multi-centre pediatric study in Canada using insulin pump therapy and continuous glucose monitoring (CGM).

JDRF Canada Continues Commitment to Groundbreaking T1D Research

Vancouver, BC (May 30, 2012) – JDRF Canada is pleased to announce the renewed funding of a study seeking to produce an alternative source of insulin-producing cells that may be used to cure type 1 diabetes (T1D).

JDRF through the Joint JDRF-Helmsley Charitable Trust Initiative Partners with Medtronic

NEW YORK, N.Y., June 1, 2012 -- JDRF in collaboration with the Helmsley Charitable Trust (HCT) announced today a partnership with Medtronic, Inc. (NYSE:MDT), a leader in artificial pancreas research and development. The JDRF-HCT Sensor Initiative aims to advance continuous glucose ...

HRH The Duchess of Cornwall to take Royal role in JDRF

JDRF, the type 1 diabetes charity, is delighted to announce that Her Royal Highness The Duchess of Cornwall has agreed to become its President. Her Royal Highness recently visited a clinical research facility in Cambridge to learn about JDRF funded research to find the cure for type 1 diabetes. ...

Lets turn type one into type none